[DPHARMA] YoY TTM Result on 31-Mar-2017 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 2.86%
YoY- -25.94%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 584,789 515,849 477,940 354,464 304,911 182,065 165,062 23.44%
PBT 69,750 65,197 52,929 32,714 47,508 47,513 42,396 8.64%
Tax -15,381 -13,738 -9,746 -5,098 -9,864 -8,428 -7,243 13.36%
NP 54,369 51,459 43,183 27,616 37,644 39,085 35,153 7.53%
-
NP to SH 54,369 51,459 43,710 27,890 37,659 36,283 35,153 7.53%
-
Tax Rate 22.05% 21.07% 18.41% 15.58% 20.76% 17.74% 17.08% -
Total Cost 530,420 464,390 434,757 326,848 267,267 142,980 129,909 26.39%
-
Net Worth 540,662 496,410 206,429 463,071 457,740 205,045 190,050 19.01%
Dividend
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Div 40,733 30,674 23,711 19,142 5,682 25,682 24,289 8.99%
Div Payout % 74.92% 59.61% 54.25% 68.64% 15.09% 70.79% 69.10% -
Equity
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Net Worth 540,662 496,410 206,429 463,071 457,740 205,045 190,050 19.01%
NOSH 684,383 661,881 278,959 278,959 278,959 139,486 138,723 30.44%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 9.30% 9.98% 9.04% 7.79% 12.35% 21.47% 21.30% -
ROE 10.06% 10.37% 21.17% 6.02% 8.23% 17.70% 18.50% -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 85.45 77.94 171.33 127.07 109.24 130.52 118.99 -5.36%
EPS 7.94 7.77 15.67 10.00 13.49 26.01 25.34 -17.57%
DPS 5.95 4.63 8.50 6.86 2.04 18.50 17.50 -16.44%
NAPS 0.79 0.75 0.74 1.66 1.64 1.47 1.37 -8.75%
Adjusted Per Share Value based on latest NOSH - 278,959
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 60.79 53.63 49.68 36.85 31.70 18.93 17.16 23.44%
EPS 5.65 5.35 4.54 2.90 3.91 3.77 3.65 7.54%
DPS 4.23 3.19 2.46 1.99 0.59 2.67 2.53 8.93%
NAPS 0.5621 0.5161 0.2146 0.4814 0.4759 0.2132 0.1976 19.01%
Price Multiplier on Financial Quarter End Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 -
Price 1.39 1.28 2.80 2.31 2.55 3.88 3.03 -
P/RPS 1.63 1.64 1.63 1.82 2.33 2.97 2.55 -7.18%
P/EPS 17.50 16.46 17.87 23.10 18.90 14.92 11.96 6.54%
EY 5.72 6.07 5.60 4.33 5.29 6.70 8.36 -6.12%
DY 4.28 3.62 3.04 2.97 0.80 4.77 5.78 -4.87%
P/NAPS 1.76 1.71 3.78 1.39 1.55 2.64 2.21 -3.72%
Price Multiplier on Announcement Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 18/05/20 21/05/19 28/05/18 22/05/17 18/05/16 18/05/15 20/05/14 -
Price 1.72 1.36 3.35 2.32 2.40 3.90 3.09 -
P/RPS 2.01 1.75 1.96 1.83 2.20 2.99 2.60 -4.19%
P/EPS 21.65 17.49 21.38 23.20 17.79 14.99 12.19 10.03%
EY 4.62 5.72 4.68 4.31 5.62 6.67 8.20 -9.11%
DY 3.46 3.41 2.54 2.96 0.85 4.74 5.66 -7.86%
P/NAPS 2.18 1.81 4.53 1.40 1.46 2.65 2.26 -0.59%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment